Mylan has spent more than $460 million buying Novartis cystic fibrosis products. Now, it wants the plant that makes them. Mylan took an option on a Novartis plant in San Carlos, California, when it ...

The Novo Nordisk A/S (NYSE:NVO) attempt to block Mylan Pharmaceuticals from launching a generic version of its weight-loss drug Wegovy hit a major obstacle as the court ruled in Mylan's favor on key ...

New Mexico has reached a $2.25 million settlement with EpiPen maker Mylan Inc. over allegations the company used anticompetitive tactics to keep prices high for the life-saving allergy device, ...

PITTSBURGH (KDKA/AP) -- Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and generic business. The Pfizer ...

Mylan's planned megamerger with Pfizer's Upjohn generics unit has had a rocky road to approval, with the novel coronavirus pandemic snagging regulatory review. Despite the delay, Mylan isn't twiddling ...

Mylan announced on its most recent quarterly earnings call that it expects to launch its rituximab and etanercept biosimilars in Europe later this year. In discussing Mylan’s biosimilars pipeline, ...

Teva Pharmaceutical must face a lawsuit claiming it used unlawful methods to block generic competition for its multiple sclerosis drug ​Copaxone, a New Jersey federal judge said on Monday.

Pharmaceutical firm Mylan is dramatically expanding a nationwide recall of some blood pressure medications after detecting trace amounts of a chemical linked to cancer. The recalled products all ...

On Sept. 27, 2019, the Securities and Exchange Commission (SEC) announced that Mylan N.V., a global pharma company that manufactures and sells EpiPen, which is used to treat serious allergic reactions ...

One of the world’s largest generic drugmakers and a division of one of the largest pharmaceutical companies are combining to create a new pharmaceutical company. Pittsburgh-based Mylan and Upjohn – ...

The myriad problems with the U.S. healthcare system aren’t the fault of any one person. But every so often, an industry executive spouts something so wrong-headed, it shines a helpful light on what we ...

Then-Mylan CEO Heather Bresch, daughter of U.S. Sen. Joe Manchin of West Virginia, takes her seat on Capitol Hill on Sept. 21, 2016, before testifying before the House Oversight Committee on EpiPen ...